Abstract | OBJECTIVE: METHODS: We describe a 31-year-old man who had rickets as a child and developed a femur insufficiency fracture and recurrent nephrolithiasis as an adult after moving to the United States from India. The patient's clinical course and results from radiographic and biochemical analyses are described. Analysis of the SLC34A3 gene was performed using genomic DNA samples from the patient and his family members. RESULTS: Before referral to the Yale Bone Center, the patient was treated with calcitriol, ergocalciferol, and phosphate. Changing therapy to phosphate alone led to clinical improvement. Genetic analysis revealed that the patient is a compound heterozygote for mutations in the SLC34A3 gene. On 1 allele, he has a previously described missense mutation in exon 7: c.575C>T (p.Ser192Leu). The other allele carries a novel nonsense mutation in exon 3: c.145C>T (p.Gln49X). One unaffected sibling is a carrier of the missense mutation and 1 sister with a history of flank pain is a carrier of the novel mutation. CONCLUSIONS:
|
Authors | Kathleen Page, Clemens Bergwitz, Graciana Jaureguiberry, Chittari V Harinarayan, Karl Insogna |
Journal | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
(Endocr Pract)
Vol. 14
Issue 7
Pg. 869-74
(Oct 2008)
ISSN: 1934-2403 [Electronic] United States |
PMID | 18996815
(Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- SLC34A3 protein, human
- Sodium-Phosphate Cotransporter Proteins, Type IIc
|
Topics |
- Adult
- Femoral Neck Fractures
(drug therapy, genetics, metabolism, pathology)
- Humans
- Hypophosphatemia
(drug therapy, genetics, metabolism, pathology)
- Kidney Calculi
(drug therapy, genetics, metabolism, pathology)
- Male
- Mutation
- Sodium-Phosphate Cotransporter Proteins, Type IIc
(genetics)
|